-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Olema Pharmaceuticals, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2019 to 2024.
- Olema Pharmaceuticals, Inc. Operating Income (Loss) for the quarter ending June 30, 2025 was -$47.9M, a 42.8% decline year-over-year.
- Olema Pharmaceuticals, Inc. Operating Income (Loss) for the twelve months ending June 30, 2025 was -$157M, a 29.2% decline year-over-year.
- Olema Pharmaceuticals, Inc. annual Operating Income (Loss) for 2024 was -$142M, a 35.5% decline from 2023.
- Olema Pharmaceuticals, Inc. annual Operating Income (Loss) for 2023 was -$105M, a 1.9% increase from 2022.
- Olema Pharmaceuticals, Inc. annual Operating Income (Loss) for 2022 was -$107M, a 49.7% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)